The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory ... fluticasone propionate 250 mcg/salmeterol 50 mcg and fluticasone propionate 500 mcg ...
While Sandoz has emerged as the front-runner to get a generic version of GlaxoSmithKline’s respiratory blockbuster Advair to the US market, rival Hikma has not given up despite a major setback.
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback